Purchases and Sales Made in Q4 2022 in Bolt Biotherapeutics, Inc. (BOLT)
This table provides information about the institutional ownership of Bolt Biotherapeutics, Inc. (BOLT) during Q4 2022. The information is specifically focused on institutions that hold shares of Bolt Biotherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Newtyn Management, LLC
New York, NY |
BUY
|
- |
550K+ 91.67% |
$693K - $831K
|
1.15M
$575K
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
271K+ 2230.41% |
$341K - $409K
|
283K
$142K
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
271K+ 2230.41% |
$341K - $409K
|
283K
$142K
|
|
|
Feb 14, 2023
Q4 2022
|
Tang Capital Management LLC
San Diego, CA |
BUY
|
- |
200K+ 100.0% |
$252K - $302K
|
400K
$200K
|
|
|
Feb 14, 2023
Q4 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
125K+ 105.61% |
$158K - $189K
|
243K
$122K
|
|
|
Feb 14, 2023
Q4 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
74.4K+ 65.72% |
$93.7K - $112K
|
188K
$93.8K
|
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
47.7K+ 12.11% |
$60.1K - $72K
|
442K
$221K
|
|
|
Jan 12, 2023
Q4 2022
|
Marquette Asset Management, LLC
|
BUY
|
- |
34.1K+ 53.4% |
$42.9K - $51.4K
|
97.8K
$48.9K
|
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
20.3KNew |
$25.6K - $30.7K
|
20.3K
$10.2K
|
|
|
Feb 13, 2023
Q4 2022
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
17.5K+ 742.13% |
$22.1K - $26.5K
|
19.9K
$9.95K
|
|
|
Feb 14, 2023
Q4 2022
|
Bank Of New York Mellon Corp
New York, NY |
BUY
|
- |
12.6KNew |
$15.9K - $19.1K
|
12.6K
$6.31K
|
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
11.9K+ 8.33% |
$14.9K - $17.9K
|
154K
$77K
|
|
|
Feb 14, 2023
Q4 2022
|
Prudential Financial Inc
Newark, NJ |
BUY
|
- |
8.2K+ 50.62% |
$10.3K - $12.4K
|
24.4K
$12.2K
|
|
|
Feb 14, 2023
Q4 2022
|
Man Group PLC
London, X0 |
BUY
|
- |
6.58K+ 36.76% |
$8.29K - $9.94K
|
24.5K
$12.2K
|
|
|
Feb 13, 2023
Q4 2022
|
Federated Hermes, Inc.
Pittsburgh, PA |
BUY
|
- |
1.89K+ 88.01% |
$2.38K - $2.85K
|
4.03K
$2.01K
|
|
|
Feb 13, 2023
Q4 2022
|
Barclays PLC
London, X0 |
BUY
|
- |
1.54K+ 1105.04% |
$1.94K - $2.32K
|
1.68K
$838
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
114+ 0.0% |
$144 - $172
|
2.75M
$1.38M
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
4+ 2.76% |
$5.04 - $6.04
|
149
$74.5
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Stifel Financial Corp
St. Louis, MO |
SELL
|
- |
-51- 0.36% |
$64.3 - $77
|
14K
$7.01K
|
|
|
Feb 10, 2023
Q4 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-381- 79.21% |
$480 - $575
|
100
$50
|
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
SELL
|
- |
-450- 91.28% |
$567 - $680
|
43
$21.5
|
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-12K- 1.28% |
$15.1K - $18.1K
|
928K
$464K
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-16.3K- 88.04% |
$20.6K - $24.6K
|
2.22K
$1.11K
|
|
|
Feb 08, 2023
Q4 2022
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-24.8K- 38.16% |
$31.2K - $37.4K
|
40.2K
$20.1K
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-36.2K- 50.9% |
$45.6K - $54.6K
|
34.9K
$17.4K
|
|
|
Jan 12, 2023
Q4 2022
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-54.2K- 19.35% |
$68.2K - $81.8K
|
226K
$113K
|
|
|
Feb 14, 2023
Q4 2022
|
Ergoteles LLC
New York, NY |
SELL
|
- |
-59.7K- 67.67% |
$75.2K - $90.1K
|
28.5K
$14.3K
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-170K- 38.38% |
$214K - $257K
|
273K
$137K
|